In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time

被引:6
|
作者
de Lange, Zelda [1 ]
Rijken, Dingeman C. [2 ]
Hoekstra, Tiny [1 ,3 ]
Conradie, Karin R. [1 ]
Jerling, Johann C. [1 ]
Pieters, Marlien [1 ]
机构
[1] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa
[2] Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
来源
PLOS ONE | 2013年 / 8卷 / 12期
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
PLASMINOGEN-ACTIVATOR INHIBITOR-1; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; VENOUS THROMBOSIS; INCOME COUNTRIES; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; CIRCULATING LEVELS; METABOLIC SYNDROME; ADIPOSE-TISSUE;
D O I
10.1371/journal.pone.0083151
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data on genetic and environmental factors influencing PAI-1 levels and their consequent effect on clot lysis in black African populations are limited. We identified polymorphisms in the promoter area of the PAI-1 gene and determined their influence on PAI-1(act) levels and plasma clot lysis time (CLT). We also describe gene-environment interactions and the effect of urbanisation. Data from 2010 apparently healthy urban and rural black participants from the South African arm of the PURE study were cross-sectionally analysed. The 5G allele frequency of the 4G/5G polymorphism was 0.85. PAI-1(act) increased across genotypes in the urban subgroup (p = 0.009) but not significantly in the rural subgroup, while CLT did not differ across genotypes. Significant interaction terms were found between the 4G/5G polymorphism and BMI, waist circumference and triglycerides in determining PAI-1(act), and between the 4G/5G polymorphism and fibrinogen and fibrinogen gamma prime in determining CLT. The C428T and G429A polymorphisms did not show direct relationships with PAI-1(act) or CLT but they did influence the association of other environmental factors with PAI-1(act) and CLT. Several of these interactions differed significantly between rural and urban subgroups, particularly in individuals harbouring the mutant alleles. In conclusion, although the 4G/5G polymorphism significantly affected PAI-1(act), it contributed less than 1% to the PAI-1(act) variance. (Central) obesity was the biggest contributor to PAI-1(act) variance (12.5%). Urbanisation significantly influenced the effect of the 4G/5G polymorphism on PAI-1(act) as well as gene-environment interactions for the C428T and G429A genotypes in determining PAI-1(act) and CLT.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study
    Prabhudesai, Aniket
    Shetty, Shrimati
    Ghosh, Kanjaksha
    Kulkarni, Bipin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (03) : 249 - 254
  • [32] Plasminogen Activator Inhibitor-1 (PAI-1) Gene 4G/5G Promoter Polymorphism is Seen in Higher Frequency in the Indian Patients With Deep Vein Thrombosis
    Akhter, Mohammed Suhail
    Biswas, Arijit
    Ranjan, Ravi
    Meena, Arvind
    Yadav, Birendra Kumar
    Sharma, Amit
    Saxena, Renu
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2010, 16 (02) : 184 - 188
  • [33] Clinical impact of PAI 1 4G/5G gene polymorphism in colorectal carcinoma patients
    Halamkova, J.
    Kiss, I.
    Pavlovsky, Z.
    Tomasek, J.
    Jarkovsky, J.
    Cech, Z.
    Bednarova, D.
    Tucek, S.
    Hanakova, L.
    Moulis, M.
    Zavrelova, J.
    Man, M.
    Benda, P.
    Robek, O.
    Kala, Z.
    Penka, M.
    NEOPLASMA, 2013, 60 (02) : 151 - 159
  • [34] Meta-analysis of the plasminogen activator inhibitor-1 (PAI-1) gene with insertion/deletion 4G/5G polymorphism and its susceptibility to ischemic stroke in Thai population
    Assawamakin, Anunchai
    Sriratanaviriyakul, Narin
    Lalerd, Yupaporn
    Thongnoppakhun, Wanna
    Praditsap, Oranud
    Tongsima, Sissades
    Pithukpakorn, Manop
    ASIAN BIOMEDICINE, 2012, 6 (02) : 203 - 217
  • [35] The association of clot lysis time with total obesity is partly independent from the association of PAI-1 with central obesity in African adults
    Eksteen, Philna
    Pieters, Marlien
    de Lange, Zelda
    Kruger, Herculina S.
    THROMBOSIS RESEARCH, 2015, 136 (02) : 415 - 421
  • [36] Association of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G and Apolipoprotein E polymorphisms with risk of Myocardial Infarction in Indian Tamil Population
    Sahana, Nair
    Vivekananda, Budamagunta
    Abinaya, Meenakshisundaram
    Hemapriyanka, S.
    Pournima, Prabhakaran
    Abirami, B. Suruthi
    Devi, A.
    ArulJothi, K. N.
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2018, 13 (01): : 91 - 98
  • [37] The-675 4G/5G PAI-1 polymorphism confers genetic susceptibility to systemic lupus erythematosus, its clinical manifestations, and comorbidities in Mexican-Mestizo population
    Anaya-Macias, B. U.
    De la Cruz-Mosso, U.
    Palafox-Sanchez, C. A.
    Parra-Rojas, I.
    Martinez-Bonilla, G.
    Gonzalez-Lopez, L.
    Gamez-Nava, J. I.
    Perez-Guerrero, E. E.
    Barrientos-Avalos, S. L.
    Munoz-Valle, J. F.
    AUTOIMMUNITY, 2020, 53 (02) : 71 - 77
  • [38] Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility A meta-analysis
    Zhang, Xin
    Gao, Bai
    Xu, Bing
    MEDICINE, 2020, 99 (50) : E23660
  • [39] Genotype Variations and Association between PAI-1 Promoter Region (4G/5G and-844G/A) and Susceptibility to Acute Myocardial Infarction and Chronic Stable Angina
    Kumar, Sunil
    Verma, Amit Kumar
    Sagar, Vinay
    Ranjan, Ravi
    Sharma, Rahul
    Tomar, Preeti
    Bhatt, Deepti
    Goyal, Yamini
    Alsahli, Mohammed A.
    Almatroudi, Ahmad
    Almatroodi, Saleh A.
    Rahmani, Arshad Husain
    Alrumaihi, Faris
    Muzammil, Khursheed
    Dev, Kapil
    Yadav, Rakesh
    Saxena, Renu
    CARDIOLOGY RESEARCH AND PRACTICE, 2021, 2021
  • [40] Isolated Renal Vein Thrombosis Associated With MTHFR-1298 and PAI-1 4G Gene Mutations
    Cinemre, Hakan
    Bilir, Cemil
    Akdemir, Nermin
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2010, 16 (06) : 708 - 710